Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1465912, 9 pages
https://doi.org/10.1155/2017/1465912
Research Article

Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1

1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Department of Gastroenterology, Jinan Hospital, Jinan, Shandong 250013, China
3Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Correspondence should be addressed to Chengyong Qin; moc.361@0002niqgnoygnehc

Received 6 September 2016; Accepted 9 January 2017; Published 5 February 2017

Academic Editor: Xin-Yuan Guan

Copyright © 2017 Miao Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. T. London and K. A. McGlynn, “Liver cancer,” in Cancer Epidemiology and Prevention, D. Schottenfeld and J. Fraumeni Jr., Eds., pp. 763–786, Oxford University Press, New York, NY, USA, 3rd edition, 2006. View at Google Scholar
  3. M. Bupathi, A. Kaseb, F. Meric-Bernstam, and A. Naing, “Hepatocellular carcinoma: where there is unmet need,” Molecular Oncology, vol. 9, no. 8, pp. 1501–1509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Oyama, G. Shiota, H. Ito, Y. Murawaki, and H. Kawasaki, “Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats,” Carcinogenesis, vol. 23, no. 5, pp. 885–892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Tarao, S. Fujiyama, S. Ohkawa et al., “Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 1, pp. 164–169, 2005. View at Google Scholar · View at Scopus
  6. E. M. M. Kuiper, B. E. Hansen, R. A. de Vries et al., “Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid,” Gastroenterology, vol. 136, no. 4, pp. 1281–1287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. de Leon, N. Carulli, P. Loria, R. Iori, and F. Zironi, “The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption,” Gastroenterology, vol. 77, no. 2, pp. 223–230, 1979. View at Google Scholar · View at Scopus
  8. S.-B. Yee, Y. S. Song, S. H. Jeong et al., “A novel chenodeoxycholic derivative HS-1200 enhances radiation-induced apoptosis in MCF-7 cells,” Oncology Reports, vol. 17, no. 4, pp. 919–923, 2007. View at Google Scholar · View at Scopus
  9. Y. H. Choi, E. O. Im, H. Suh, Y. Jin, Y. H. Yoo, and N. D. Kim, “Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells,” Cancer Letters, vol. 199, no. 2, pp. 157–167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. E. Park, H. J. Choi, S. B. Yee et al., “Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells,” International journal of oncology, vol. 25, no. 1, pp. 231–236, 2004. View at Google Scholar · View at Scopus
  11. H. Liu, C.-K. Qin, G.-Q. Han, H.-W. Xu, W.-H. Ren, and C.-Y. Qin, “Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway,” Cancer Letters, vol. 270, no. 2, pp. 242–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Park, S. W. Lee, M. A. Hossain et al., “A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells,” Cancer Letters, vol. 270, no. 1, pp. 77–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Nishida and M. Kudo, “Oxidative stress and epigenetic instability in human hepatocarcinogenesis,” Digestive Diseases, vol. 31, no. 5-6, pp. 447–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Cardin, M. Piciocchi, M. Bortolami et al., “Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway,” World Journal of Gastroenterology, vol. 20, no. 12, pp. 3078–3086, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Ziech, R. Franco, A. Pappa, and M. I. Panayiotidis, “Reactive Oxygen Species (ROS)—induced genetic and epigenetic alterations in human carcinogenesis,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 711, no. 1-2, pp. 167–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Chuma, S. Hige, M. Nakanishi et al., “8-Hydroxy-2′-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection,” Journal of Gastroenterology and Hepatology, vol. 23, no. 9, pp. 1431–1436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Nakabeppu, S. Oka, Z. Sheng, D. Tsuchimoto, and K. Sakumi, “Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 703, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Gad, T. Koolmeister, A.-S. Jemth et al., “MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool,” Nature, vol. 508, no. 7495, pp. 215–221, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Iida, A. Furuta, Y. Nakabeppu, and T. Iwaki, “Defense mechanism to oxidative DNA damage in glial cells,” Neuropathology, vol. 24, no. 2, pp. 125–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Okamoto, S. Toyokuni, W.-J. Kim et al., “Overexpression of human mutT homologue gene messenger RNA in renal-cell carcinoma: evidence of persistent oxidative stress in cancer,” International Journal of Cancer, vol. 65, no. 4, pp. 437–441, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Wani, G. E. Milo, and S. M. D'Ambrosio, “Enhanced expression of the 8-oxo-7,8-dihydrodeoxyguanosine triphosphatase gene in human breast tumor cells,” Cancer Letters, vol. 125, no. 1-2, pp. 123–130, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Koketsu, T. Watanabe, and H. Nagawa, “Expression of DNA repair protein: MYH, NTH1, and MTH1 in colorectal cancer,” Hepato-Gastroenterology, vol. 51, no. 57, pp. 638–642, 2004. View at Google Scholar · View at Scopus
  23. C. Jüngst, B. Cheng, R. Gehrke et al., “Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma,” Hepatology, vol. 39, no. 6, pp. 1663–1672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Paula Santos, A. Colaço, R. M. Gil da Costa, M. Manuel Oliveira, F. Peixoto, and P. Alexandra Oliveira, “N-diethylnitrosamine mouse hepatotoxicity: time-related effects on histology and oxidative stress,” Experimental and Toxicologic Pathology, vol. 66, no. 9-10, pp. 429–436, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. G. Marin, R. I. R. Macias, O. Briz, J. M. Banales, and M. J. Monte, “Bile acids in physiology, pathology and pharmacology,” Current Drug Metabolism, vol. 17, no. 1, pp. 4–29, 2015. View at Google Scholar · View at Scopus
  26. M. Trauner, P. J. Meier, and J. L. Boyer, “Molecular pathogenesis of cholestasis,” The New England Journal of Medicine, vol. 339, no. 17, pp. 1217–1227, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Liang, Q. Zhou, J. Zhang et al., “A novel chenodeoxycholic acid-verticinone ester induces apoptosis and cell cycle arrest in HepG2 cells,” Steroids, vol. 77, no. 13, pp. 1381–1390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E.-O. Im, Y. H. Choi, K.-J. Paik et al., “Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells,” Cancer Letters, vol. 163, no. 1, pp. 83–93, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Liu, H.-W. Xu, Y.-Z. Zhang et al., “Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice,” World Journal of Gastroenterology, vol. 21, no. 36, pp. 10367–10374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. N. C. Teoh, Y. Y. Dan, K. Swisshelm et al., “Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice,” Hepatology, vol. 47, no. 6, pp. 2078–2088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Sekiguchi and T. Tsuzuki, “Oxidative nucleotide damage: consequences and prevention,” Oncogene, vol. 21, no. 58, pp. 8895–8904, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Rai, J. J. Young, D. G. A. Burton, M. G. Giribaldi, T. T. Onder, and R. A. Weinberg, “Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence,” Oncogene, vol. 30, no. 12, pp. 1489–1496, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Obtułowicz, M. Swoboda, E. Speina et al., “Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients,” Mutagenesis, vol. 25, no. 5, pp. 463–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Borrego, A. Vazquez, F. Dasí et al., “Oxidative stress and DNA damage in human gastric carcinoma: 8-Oxo-7'8-dihydro-2'-deoxyguanosine (8-oxo-dG) as a possible tumor marker,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 3467–3486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Kennedy, R. Cueto, S. A. Belinsky, J. F. Lechner, and W. A. Pryor, “Overexpression of hMTH1 mRNA: A molecular marker of oxidative stress in lung cancer cells,” FEBS Letters, vol. 429, no. 1, pp. 17–20, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Nakabeppu, “Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage,” Progress in Nucleic Acid Research and Molecular Biology, vol. 68, pp. 75–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Nakabeppu, “Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 12543–12557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. K. V. M. Huber, E. Salah, B. Radic et al., “Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy,” Nature, vol. 508, no. 7495, pp. 222–227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Tsuzuki, A. Egashira, H. Igarashi et al., “Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11456–11461, 2001. View at Publisher · View at Google Scholar · View at Scopus